497 related articles for article (PubMed ID: 34905377)
1. The Repertoire of Small-Molecule PET Probes for Neuroinflammation Imaging: Challenges and Opportunities beyond TSPO.
Chen Z; Haider A; Chen J; Xiao Z; Gobbi L; Honer M; Grether U; Arnold SE; Josephson L; Liang SH
J Med Chem; 2021 Dec; 64(24):17656-17689. PubMed ID: 34905377
[TBL] [Abstract][Full Text] [Related]
2. Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO.
Narayanaswami V; Dahl K; Bernard-Gauthier V; Josephson L; Cumming P; Vasdev N
Mol Imaging; 2018; 17():1536012118792317. PubMed ID: 30203712
[TBL] [Abstract][Full Text] [Related]
3. Recent Developments in TSPO PET Imaging as A Biomarker of Neuroinflammation in Neurodegenerative Disorders.
Werry EL; Bright FM; Piguet O; Ittner LM; Halliday GM; Hodges JR; Kiernan MC; Loy CT; Kril JJ; Kassiou M
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261683
[TBL] [Abstract][Full Text] [Related]
4. Imaging Microglial Activation with TSPO PET: Lighting Up Neurologic Diseases?
Vivash L; O'Brien TJ
J Nucl Med; 2016 Feb; 57(2):165-8. PubMed ID: 26697963
[TBL] [Abstract][Full Text] [Related]
5. Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases.
Dupont AC; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Tronel C; Arlicot N
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28387722
[TBL] [Abstract][Full Text] [Related]
6. Development of brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer's disease.
Janssen B; Mach RH
Prog Mol Biol Transl Sci; 2019; 165():371-399. PubMed ID: 31481170
[TBL] [Abstract][Full Text] [Related]
7. PET Imaging of Neuroinflammation in Alzheimer's Disease.
Zhou R; Ji B; Kong Y; Qin L; Ren W; Guan Y; Ni R
Front Immunol; 2021; 12():739130. PubMed ID: 34603323
[TBL] [Abstract][Full Text] [Related]
8. Essential Principles and Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging.
Viviano M; Barresi E; Siméon FG; Costa B; Taliani S; Da Settimo F; Pike VW; Castellano S
Curr Med Chem; 2022 Aug; 29(28):4862-4890. PubMed ID: 35352645
[TBL] [Abstract][Full Text] [Related]
9. Towards PET imaging of the dynamic phenotypes of microglia.
Beaino W; Janssen B; Vugts DJ; de Vries HE; Windhorst AD
Clin Exp Immunol; 2021 Dec; 206(3):282-300. PubMed ID: 34331705
[TBL] [Abstract][Full Text] [Related]
10. Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging.
Cerami C; Iaccarino L; Perani D
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475165
[TBL] [Abstract][Full Text] [Related]
11. Imaging Neuroinflammation in Neurodegenerative Disorders.
Masdeu JC; Pascual B; Fujita M
J Nucl Med; 2022 Jun; 63(Suppl 1):45S-52S. PubMed ID: 35649654
[TBL] [Abstract][Full Text] [Related]
12. Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: An update.
Gouilly D; Saint-Aubert L; Ribeiro MJ; Salabert AS; Tauber C; Péran P; Arlicot N; Pariente J; Payoux P
Eur J Neurosci; 2022 Mar; 55(5):1322-1343. PubMed ID: 35083791
[TBL] [Abstract][Full Text] [Related]
13. Imaging neuroinflammation with TSPO: A new perspective on the cellular sources and subcellular localization.
Guilarte TR; Rodichkin AN; McGlothan JL; Acanda De La Rocha AM; Azzam DJ
Pharmacol Ther; 2022 Jun; 234():108048. PubMed ID: 34848203
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
[TBL] [Abstract][Full Text] [Related]
15. [
Kim K; Kim H; Bae SH; Lee SY; Kim YH; Na J; Lee CH; Lee MS; Ko GB; Kim KY; Lee SH; Song IH; Cheon GJ; Kang KW; Kim SE; Chung JK; Kim EE; Paek SH; Lee JS; Lee BC; Youn H
Theranostics; 2020; 10(20):9315-9331. PubMed ID: 32802194
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease.
Vicente-Rodríguez M; Mancuso R; Peris-Yague A; Simmons C; ; Gómez-Nicola D; Perry VH; Turkheimer F; Lovestone S; Parker CA; Cash D
J Neuroinflammation; 2023 Apr; 20(1):92. PubMed ID: 37032328
[TBL] [Abstract][Full Text] [Related]
17. Neuroinflammation in dementia: A meta-analysis of PET imaging studies.
Pan J; Hu J; Meng D; Chen L; Wei X
Medicine (Baltimore); 2024 May; 103(18):e38086. PubMed ID: 38701247
[TBL] [Abstract][Full Text] [Related]
18. The Low-Affinity Binding of Second Generation Radiotracers Targeting TSPO is Associated with a Unique Allosteric Binding Site.
Rojas C; Stathis M; Coughlin JM; Pomper M; Slusher BS
J Neuroimmune Pharmacol; 2018 Mar; 13(1):1-5. PubMed ID: 28875261
[TBL] [Abstract][Full Text] [Related]
19. New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease.
Best L; Ghadery C; Pavese N; Tai YF; Strafella AP
Curr Neurol Neurosci Rep; 2019 Apr; 19(5):24. PubMed ID: 30941587
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the novel TSPO radiotracer 2-(7-butyl-2-(4-(2-([
Tang D; Fujinaga M; Hatori A; Zhang Y; Yamasaki T; Xie L; Mori W; Kumata K; Liu J; Manning HC; Huang G; Zhang MR
Eur J Med Chem; 2018 Apr; 150():1-8. PubMed ID: 29505933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
